Aptevo Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare Conference

SEATTLE, Nov. 23, 2016 (GLOBE NEWSWIRE) — Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, today announced that it will present at the 28th Annual Piper Jaffray Healthcare Conference on Wednesday, November 30, 2016 at 1:00 pm EST at the Lotte New York Palace Hotel.

A live audio webcast of the presentation can be accessed at www.aptevotherapeutics.com under the ‘Investors’ section of the website, under ‘Events.’  An audio reply of the webcast will be available following the live webcast.

About Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc. is a biotechnology company focused on novel oncology and hematology therapeutics to meaningfully improve patients’ lives. Our core technology is the ADAPTIR™ (modular protein technology) platform. Aptevo has four commercial products in the areas of hematology and infectious diseases, as well as various investigational stage product candidates in immuno-oncology.

Aptevo Therapeutics
Stacey Jurchison
Senior Director, Investor Relations and Corporate Communications


You May Also Like

Curis and Aurigene Present Preclinical Data from Multiple Programs at AACR Annual Meeting

LEXINGTON, Mass., April 20, 2016 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company ...

Intercept Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Business Update

Worldwide net Ocaliva® (obeticholic acid or OCA) 1Q 2017 sales of $20.6 millionCompleted enrollment ...

Argos Announces One-for-Twenty Reverse Stock Split

DURHAM, N.C., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ:ARGS), an immuno-oncology ...